Drug application
LIBRELEASE (CHLORDIAZEPOXIDE)
Drugs@FDA NDA 017813 · VALEANT PHARM INTL
Key facts
| Drug name | LIBRELEASE |
|---|---|
| Active ingredients | CHLORDIAZEPOXIDE |
| Application type | NDA |
| Application number | 017813 |
| Company | VALEANT PHARM INTL |
| Dosage forms | CAPSULE, EXTENDED RELEASE, ORAL |
| Strength | 30MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Sep 12, 1983 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.